Data gathered: April 22
AI Stock Analysis - Shattuck Labs (STTK)
Analysis generated March 2, 2025. Powered by Chat GPT.
Shattuck Labs is a biopharmaceutical company focusing on novel treatments for cancer and autoimmune diseases. Renowned for their proprietary Agonist Redirected Checkpoint (ARC) platform, Shattuck Labs aims to develop therapies that surpass the limitations of current immunotherapies. The company is dedicated to a pipeline of clinical-stage and preclinical therapies, with strong collaborations in the pharmaceutical industry.
Stock Alerts - Shattuck Labs (STTK)
 |
Shattuck Labs | April 22 Price is up by 9.5% in the last 24h. |
|
Shattuck Labs | April 16 Price is down by -7.1% in the last 24h. |
|
Shattuck Labs | April 14 Price is down by -8.8% in the last 24h. |
|
Shattuck Labs | April 9 Price is down by -5.5% in the last 24h. |
Alternative Data for Shattuck Labs
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 75 | Sign up | Sign up | Sign up |
| Webpage traffic | 3,000 | Sign up | Sign up | Sign up |
| Employee Rating | 96 | Sign up | Sign up | Sign up |
| Google Trends | 6 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 521 | Sign up | Sign up | Sign up |
| Twitter Mentions | 63 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 87 | Sign up | Sign up | Sign up |
| Linkedin Employees | 55 | Sign up | Sign up | Sign up |
About Shattuck Labs
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States.
| Price | $0.89 |
| Target Price | Sign up |
| Volume | 167,110 |
| Market Cap | $38M |
| Year Range | $0.73 - $3.87 |
| Dividend Yield | 0% |
| Analyst Rating | 40% buy |
| Industry | Biotechnology |
In the news
 |
Analysts Set Shattuck Labs, Inc. (NASDAQ:STTK) PT at $7.50April 15 - ETF Daily News |
 |
Shattuck Labs (NASDAQ:STTK) and Dianthus Therapeutics (NASDAQ:DNTH) Head to Head ComparisonApril 15 - ETF Daily News |
 |
Shattuck Labs Announces Participation in Upcoming 24th Annual Needham Virtual Healthcare ConferenceApril 2 - Yahoo |
|
Virtu Financial LLC Invests $30,000 in Shattuck Labs, Inc. (NASDAQ:STTK)April 2 - ETF Daily News |
|
HC Wainwright Weighs in on Shattuck Labs Q1 EarningsMarch 31 - ETF Daily News |
|
HC Wainwright Reaffirms “Neutral” Rating for Shattuck Labs (NASDAQ:STTK)March 28 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q4 '24 | 0 | 0 | 0 | -19M | -19M | -0.370 |
| Q3 '24 | 3M | 0 | 3M | -17M | -17M | -0.330 |
| Q2 '24 | 1.6M | 19M | -18M | -22M | -22M | -0.420 |
| Q1 '24 | 1.1M | 970,000 | 140,000 | -19M | -19M | -0.370 |
| Q4 '23 | 710,000 | 980,000 | -270,000 | -18M | -18M | -0.410 |
Insider Transactions View All
| Redmile Group, LLC filed to buy 5,539,724 shares at $1.3. December 6 '24 |
| Schreiber Taylor filed to buy 71,002 shares at $1.2. October 8 '24 |
| Brous Tyler filed to buy 238,088 shares at $3.9. July 1 '24 |
| Brous Tyler filed to buy 235,088 shares at $3.9. July 1 '24 |
| Schreiber Taylor filed to buy 34,502 shares at $3.5. June 26 '24 |
Similar companies
Read more about Shattuck Labs (STTK) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Shattuck Labs?
The Market Cap of Shattuck Labs is $38M.
What is the current stock price of Shattuck Labs?
Currently, the price of one share of Shattuck Labs stock is $0.89.
How can I analyze the STTK stock price chart for investment decisions?
The STTK stock price chart above provides a comprehensive visual representation of Shattuck Labs' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Shattuck Labs shares. Our platform offers an up-to-date STTK stock price chart, along with technical data analysis and alternative data insights.
Does STTK offer dividends to its shareholders?
As of our latest update, Shattuck Labs (STTK) does not offer dividends to its shareholders. Investors interested in Shattuck Labs should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Shattuck Labs?
Some of the similar stocks of Shattuck Labs are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.